Reports Q1 revenue $690.2M, consensus $677.42M. “It was a strong start to 2025 for Ryan Specialty (RYAN) as we continue to deliver the innovative solutions our clients and trading partners have come to expect,” said Patrick G. Ryan, Founder and Executive Chairman of Ryan Specialty. “We grew total revenue 25%, supported by organic growth of nearly 13% and excellent contributions from M&A, which also added 13% to our top line, partially offset by a slight decline in fiduciary investment income. We grew Adjusted EBITDAC 27.5% while continuing to expand our margins and grew Adjusted Diluted EPS by 11.4%. We believe we remain well positioned to deliver another strong year across the firm.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RYAN:
- Ryan Specialty price target lowered to $83 from $88 at Barclays
- Ryan Specialty price target raised to $78 from $75 at Morgan Stanley
- Ryan Specialty initiated with a Buy at TD Cowen
- Ryan Specialty price target lowered to $66 from $69 at Wells Fargo
- Ryan Specialty price target lowered to $75 from $76 at Keefe Bruyette